CEMEX SAB-SPONS ADR PART CER (CX) Fundamental Analysis & Valuation

NYSE:CX • US1512908898

Current stock price

11.23 USD
-0.36 (-3.11%)
At close:
11.26 USD
+0.03 (+0.27%)
After Hours:

This CX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CX Profitability Analysis

1.1 Basic Checks

  • In the past year CX was profitable.
  • CX had a positive operating cash flow in the past year.
  • In the past 5 years CX has always been profitable.
  • Each year in the past 5 years CX had a positive operating cash flow.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.31%, CX is doing worse than 69.23% of the companies in the same industry.
  • CX has a Return On Equity of 7.21%. This is in the lower half of the industry: CX underperforms 69.23% of its industry peers.
  • CX has a Return On Invested Capital of 2.88%. This is amonst the worse of the industry: CX underperforms 84.62% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CX is below the industry average of 8.83%.
Industry RankSector Rank
ROA 3.31%
ROE 7.21%
ROIC 2.88%
ROA(3y)2.2%
ROA(5y)2.53%
ROE(3y)4.91%
ROE(5y)6.11%
ROIC(3y)4.77%
ROIC(5y)4.79%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10 -15

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.93%, CX is doing worse than 61.54% of the companies in the same industry.
  • CX's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 6.18%, CX is doing worse than 84.62% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CX has declined.
  • The Gross Margin of CX (32.86%) is better than 69.23% of its industry peers.
  • In the last couple of years the Gross Margin of CX has remained more or less at the same level.
Industry RankSector Rank
OM 6.18%
PM (TTM) 5.93%
GM 32.86%
OM growth 3Y-14.66%
OM growth 5Y-9.41%
PM growth 3Y-6.41%
PM growth 5YN/A
GM growth 3Y2.07%
GM growth 5Y0.46%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

2

2. CX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CX is destroying value.
  • The debt/assets ratio for CX has been reduced compared to a year ago.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 1.54, we must say that CX is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.54, CX is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
  • CX has a debt to FCF ratio of 10.19. This is a negative value and a sign of low solvency as CX would need 10.19 years to pay back of all of its debts.
  • The Debt to FCF ratio of CX (10.19) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.40 indicates that CX is not too dependend on debt financing.
  • CX's Debt to Equity ratio of 0.40 is fine compared to the rest of the industry. CX outperforms 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 10.19
Altman-Z 1.54
ROIC/WACC0.22
WACC13.33%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • CX has a Current Ratio of 0.83. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CX has a Current ratio of 0.83. This is amonst the worse of the industry: CX underperforms 84.62% of its industry peers.
  • CX has a Quick Ratio of 0.83. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.62, CX is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.62
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. CX Growth Analysis

3.1 Past

  • The earnings per share for CX have decreased strongly by -93.26% in the last year.
  • The earnings per share for CX have been decreasing by -11.13% on average. This is quite bad
  • The Revenue for CX has decreased by -20.06% in the past year. This is quite bad
  • The Revenue has been growing slightly by 4.71% on average over the past years.
EPS 1Y (TTM)-93.26%
EPS 3Y-11.13%
EPS 5YN/A
EPS Q2Q%-933.33%
Revenue 1Y (TTM)-20.06%
Revenue growth 3Y1.17%
Revenue growth 5Y4.71%
Sales Q2Q%9.66%

3.2 Future

  • CX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 117.58% yearly.
  • Based on estimates for the next years, CX will show a small growth in Revenue. The Revenue will grow by 5.95% on average per year.
EPS Next Y665.92%
EPS Next 2Y195.22%
EPS Next 3Y117.58%
EPS Next 5YN/A
Revenue Next Year5.8%
Revenue Next 2Y5.06%
Revenue Next 3Y4.44%
Revenue Next 5Y5.95%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 -4

7

4. CX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 28.79, CX can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of CX is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 25.60, CX is valued at the same level.
  • CX is valuated cheaply with a Price/Forward Earnings ratio of 3.76.
  • 100.00% of the companies in the same industry are more expensive than CX, based on the Price/Forward Earnings ratio.
  • CX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.79
Fwd PE 3.76
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CX indicates a rather cheap valuation: CX is cheaper than 84.62% of the companies listed in the same industry.
  • CX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CX is cheaper than 92.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.48
EV/EBITDA 9.14
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • CX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CX's earnings are expected to grow with 117.58% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y195.22%
EPS Next 3Y117.58%

6

5. CX Dividend Analysis

5.1 Amount

  • CX has a Yearly Dividend Yield of 25.02%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.43, CX pays a better dividend. On top of this CX pays more dividend than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.88, CX pays a better dividend.
Industry RankSector Rank
Dividend Yield 25.02%

5.2 History

  • CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

  • CX pays out 13.28% of its income as dividend. This is a sustainable payout ratio.
DP13.28%
EPS Next 2Y195.22%
EPS Next 3Y117.58%
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B
CX Dividend Payout.CX Dividend Payout, showing the Payout Ratio.CX Dividend Payout.PayoutRetained Earnings

CX Fundamentals: All Metrics, Ratios and Statistics

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (4/2/2026, 8:17:20 PM)

After market: 11.26 +0.03 (+0.27%)

11.23

-0.36 (-3.11%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-05
Earnings (Next)04-23
Inst Owners24.44%
Inst Owner Change-4.34%
Ins OwnersN/A
Ins Owner Change0%
Market Cap16.29B
Revenue(TTM)16.20B
Net Income(TTM)960.16M
Analysts78.67
Price Target12.86 (14.51%)
Short Float %0.48%
Short Ratio0.96
Dividend
Industry RankSector Rank
Dividend Yield 25.02%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP13.28%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-11
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-96.76%
Min EPS beat(2)-180.91%
Max EPS beat(2)-12.62%
EPS beat(4)0
Avg EPS beat(4)-61.97%
Min EPS beat(4)-180.91%
Max EPS beat(4)-2.91%
EPS beat(8)1
Avg EPS beat(8)140.94%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.42%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)2.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.78%
Min Revenue beat(4)-6.15%
Max Revenue beat(4)2.44%
Revenue beat(8)1
Avg Revenue beat(8)-3.6%
Revenue beat(12)2
Avg Revenue beat(12)-2.83%
Revenue beat(16)3
Avg Revenue beat(16)2.39%
PT rev (1m)0%
PT rev (3m)8.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)7.41%
EPS NY rev (3m)7.41%
Revenue NQ rev (1m)1.71%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0.41%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 28.79
Fwd PE 3.76
P/S 1.01
P/FCF 24.48
P/OCF 8.18
P/B 1.22
P/tB 3.92
EV/EBITDA 9.14
EPS(TTM)0.39
EY3.47%
EPS(NY)2.99
Fwd EY26.6%
FCF(TTM)0.46
FCFY4.09%
OCF(TTM)1.37
OCFY12.22%
SpS11.17
BVpS9.18
TBVpS2.86
PEG (NY)0.04
PEG (5Y)N/A
Graham Number8.97
Profitability
Industry RankSector Rank
ROA 3.31%
ROE 7.21%
ROCE 4.64%
ROIC 2.88%
ROICexc 3.17%
ROICexgc 5.95%
OM 6.18%
PM (TTM) 5.93%
GM 32.86%
FCFM 4.11%
ROA(3y)2.2%
ROA(5y)2.53%
ROE(3y)4.91%
ROE(5y)6.11%
ROIC(3y)4.77%
ROIC(5y)4.79%
ROICexc(3y)5.11%
ROICexc(5y)5.06%
ROICexgc(3y)9.64%
ROICexgc(5y)9.52%
ROCE(3y)7.68%
ROCE(5y)7.72%
ROICexgc growth 3Y-11.86%
ROICexgc growth 5Y-4.38%
ROICexc growth 3Y-12.5%
ROICexc growth 5Y-3.71%
OM growth 3Y-14.66%
OM growth 5Y-9.41%
PM growth 3Y-6.41%
PM growth 5YN/A
GM growth 3Y2.07%
GM growth 5Y0.46%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 10.19
Debt/EBITDA 2.32
Cap/Depr 102.66%
Cap/Sales 8.18%
Interest Coverage 2.25
Cash Conversion 86.85%
Profit Quality 69.32%
Current Ratio 0.83
Quick Ratio 0.62
Altman-Z 1.54
F-Score5
WACC13.33%
ROIC/WACC0.22
Cap/Depr(3y)100.55%
Cap/Depr(5y)96.93%
Cap/Sales(3y)7.66%
Cap/Sales(5y)7.33%
Profit Quality(3y)231.91%
Profit Quality(5y)171.51%
High Growth Momentum
Growth
EPS 1Y (TTM)-93.26%
EPS 3Y-11.13%
EPS 5YN/A
EPS Q2Q%-933.33%
EPS Next Y665.92%
EPS Next 2Y195.22%
EPS Next 3Y117.58%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.06%
Revenue growth 3Y1.17%
Revenue growth 5Y4.71%
Sales Q2Q%9.66%
Revenue Next Year5.8%
Revenue Next 2Y5.06%
Revenue Next 3Y4.44%
Revenue Next 5Y5.95%
EBIT growth 1Y-55.65%
EBIT growth 3Y-13.66%
EBIT growth 5Y-5.14%
EBIT Next Year100.06%
EBIT Next 3Y30.82%
EBIT Next 5YN/A
FCF growth 1Y11.3%
FCF growth 3Y18.2%
FCF growth 5Y-8.26%
OCF growth 1Y5.11%
OCF growth 3Y10.51%
OCF growth 5Y4.3%

CEMEX SAB-SPONS ADR PART CER / CX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CEMEX SAB-SPONS ADR PART CER (CX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CX.


What is the valuation status for CX stock?

ChartMill assigns a valuation rating of 7 / 10 to CEMEX SAB-SPONS ADR PART CER (CX). This can be considered as Undervalued.


How profitable is CEMEX SAB-SPONS ADR PART CER (CX) stock?

CEMEX SAB-SPONS ADR PART CER (CX) has a profitability rating of 3 / 10.


What is the valuation of CEMEX SAB-SPONS ADR PART CER based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CEMEX SAB-SPONS ADR PART CER (CX) is 28.79 and the Price/Book (PB) ratio is 1.22.


What is the earnings growth outlook for CEMEX SAB-SPONS ADR PART CER?

The Earnings per Share (EPS) of CEMEX SAB-SPONS ADR PART CER (CX) is expected to grow by 665.92% in the next year.